These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 37925000

  • 1. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
    Yu XH, Lv Z, Zhang CE, Gao Y, Li H, Ma XJ, Ma ZJ, Su JR, Huang LQ.
    J Ethnopharmacol; 2024 Feb 10; 320():117384. PubMed ID: 37925000
    [Abstract] [Full Text] [Related]

  • 2. Integrated serum pharmacochemistry and metabolomics reveal potential effective components and mechanisms of Shengjiang Xiexin decoction in the treatment of Clostridium difficile infection.
    Cui Y, Zhang C, Zhang X, Yu X, Ma Y, Qin X, Ma Z.
    Heliyon; 2023 May 10; 9(5):e15602. PubMed ID: 37206044
    [Abstract] [Full Text] [Related]

  • 3. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
    McDonald JAK, Mullish BH, Pechlivanis A, Liu Z, Brignardello J, Kao D, Holmes E, Li JV, Clarke TB, Thursz MR, Marchesi JR.
    Gastroenterology; 2018 Nov 10; 155(5):1495-1507.e15. PubMed ID: 30025704
    [Abstract] [Full Text] [Related]

  • 4. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection.
    Mullish BH, McDonald JAK, Pechlivanis A, Allegretti JR, Kao D, Barker GF, Kapila D, Petrof EO, Joyce SA, Gahan CGM, Glegola-Madejska I, Williams HRT, Holmes E, Clarke TB, Thursz MR, Marchesi JR.
    Gut; 2019 Oct 10; 68(10):1791-1800. PubMed ID: 30816855
    [Abstract] [Full Text] [Related]

  • 5. Gut microbiome and plasma lipidome analysis reveals a specific impact of Clostridioides difficile infection on intestinal bacterial communities and sterol metabolism.
    Arcay R, Barceló-Nicolau M, Suárez L, Martín L, Reigada R, Höring M, Liebisch G, Garrido C, Cabot G, Vílchez H, Cortés-Lara S, González de Herrero E, López-Causapé C, Oliver A, Barceló-Coblijn G, Mena A.
    mBio; 2024 Oct 16; 15(10):e0134724. PubMed ID: 39189787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection.
    Seekatz AM, Safdar N, Khanna S.
    Therap Adv Gastroenterol; 2022 Oct 16; 15():17562848221134396. PubMed ID: 36425405
    [Abstract] [Full Text] [Related]

  • 10. A strain of Bacteroides thetaiotaomicron attenuates colonization of Clostridioides difficile and affects intestinal microbiota and bile acids profile in a mouse model.
    Li X, Kang Y, Huang Y, Xiao Y, Song L, Lu S, Ren Z.
    Biomed Pharmacother; 2021 May 16; 137():111290. PubMed ID: 33508620
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functional Intestinal Bile Acid 7α-Dehydroxylation by Clostridium scindens Associated with Protection from Clostridium difficile Infection in a Gnotobiotic Mouse Model.
    Studer N, Desharnais L, Beutler M, Brugiroux S, Terrazos MA, Menin L, Schürch CM, McCoy KD, Kuehne SA, Minton NP, Stecher B, Bernier-Latmani R, Hapfelmeier S.
    Front Cell Infect Microbiol; 2016 May 16; 6():191. PubMed ID: 28066726
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA, Tomkovich S, Henry A, Taylor A, Colovas J, Bishop L, McBride K, Schloss PD.
    mBio; 2022 Aug 30; 13(4):e0136422. PubMed ID: 35913161
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.
    Seekatz AM, Theriot CM, Rao K, Chang YM, Freeman AE, Kao JY, Young VB.
    Anaerobe; 2018 Oct 30; 53():64-73. PubMed ID: 29654837
    [Abstract] [Full Text] [Related]

  • 17. The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection.
    Mullish BH, Allegretti JR.
    Therap Adv Gastroenterol; 2021 Oct 30; 14():17562848211017725. PubMed ID: 34104212
    [Abstract] [Full Text] [Related]

  • 18. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
    Zhang L, Dong D, Jiang C, Li Z, Wang X, Peng Y.
    Anaerobe; 2015 Aug 30; 34():1-7. PubMed ID: 25817005
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease.
    Chen LA, Oliva-Hemker M, Radin A, Weidner M, O'Laughlin BD, Sears CL, Javitt NB, Hourigan SK.
    J Crohns Colitis; 2023 Aug 21; 17(8):1364-1368. PubMed ID: 36988432
    [Abstract] [Full Text] [Related]

  • 20. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L, Barron MR, George JM, Dieterle MG, Vendrov KC, Bergin IL, Young VB.
    mBio; 2021 Jun 29; 12(3):e0273320. PubMed ID: 34126769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.